Immune (Idiopathic) Thrombocytopenic Purpura (ITP) News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Highland nurse receives DAISY Award - Belleville News-Democrat



Belleville News-Democrat
 
Highland nurse receives DAISY Award 
Belleville News-Democrat
Patrick died at the age of 33 in late 1999 from complications of Idiopathic Thrombocytopenic Purpura (ITP), a little known but not uncommon auto-immune disease. The care Patrick and his family received from nurses while he was ill inspired this unique ...

and more » 


DAISY Award honors nurse at TAMC's Aroostook Health Center in Mars Hill - WAGM



WAGM
 
DAISY Award honors nurse at TAMC's Aroostook Health Center in Mars Hill 
WAGM
Patrick died at the age of 33 in late 1999 from complications of Idiopathic Thrombocytopenic Purpura (ITP), a little known but not uncommon auto-immune disease. The care Patrick and his family received from nurses while he was ill inspired this unique ...

 


Stamps receives DAISY award from Merit Health - Vicksburg Post



Vicksburg Post
 
Stamps receives DAISY award from Merit Health 
Vicksburg Post
... and compassion when dealing with patients and their families and helping nurses see in themselves what their patients, families and colleagues see in them. The award was developed by the family of Patrick Barnes, who contracted and died from the ...

 


January 2018 SBL DAISY Nurse Award Recipient | Local News ... - Shelbyville Daily Union



Shelbyville Daily Union
 
January 2018 SBL DAISY Nurse Award Recipient | Local News ... 
Shelbyville Daily Union
Lexi Walk, RN, was honored with the DAISY Award for Extraordinary Nurses at Sarah Bush Lincoln on Jan. 22.

and more » 


11 Things That Can Raise Your Risk of Blood Clots - SELF



SELF
 
11 Things That Can Raise Your Risk of Blood Clots 
SELF
Some bleeding disorders, like hemophilia and idiopathic thrombocytopenic purpura (ITP), cause your blood to not clot enough. Others, like Factor V Leiden, fall on the opposite side of the spectrum. These can make your blood hypercoagulable, meaning it ...

 


6 Signs You Might Have This Rare Bruising and Bleeding Disorder - SELF



SELF
 
6 Signs You Might Have This Rare Bruising and Bleeding Disorder 
SELF
The rare bruising and bleeding disorder idiopathic thromocytopenic purpura (ITP) may not be high on your list of health conditions to stay up Googling until 1:00 A.M. After all, bruises are usually just a normal part of life, and your blood isn't ...

 


Clinical Practice Updates in the Management Of Immune Thrombocytopenia - P&T Community



Clinical Practice Updates in the Management Of Immune Thrombocytopenia 
P&T Community
Immune thrombocytopenia (ITP), previously called idiopathic thrombocytopenia purpura, is an autoimmune disorder characterized by a severe reduction in peripheral blood platelet count. In healthy individuals, normal platelet count ranges from 150?450 ...

 


Novartis drug RevoladeŽ shows long-term disease control for ... - GlobeNewswire (press release)



Novartis drug RevoladeŽ shows long-term disease control for ... 
GlobeNewswire (press release)
Basel, October 18, 2017 - Novartis today announced long-term study results supporting the positive safety and efficacy of Revolade (eltrombopag) in adults with chronic/persistent (enrolling patients that were 6 or more months from diagnosis) immune ...

and more » 


Role of Polymorphisms in Idiopathic Thrombocytopenic Purpura: A Review - Oncology Nurse Advisor



Oncology Nurse Advisor
 
Role of Polymorphisms in Idiopathic Thrombocytopenic Purpura: A Review 
Oncology Nurse Advisor
The main cause of ITP remains unidentified; however, researchers suggest that certain polymorphisms in respective genes are potential factors for ITP. Immune thrombocytopenic purpura (ITP) is an autoimmune disease in which the body increases antibody ...

 


Promacta receives Breakthrough Therapy designation for SAA - European Pharmaceutical Review



European Pharmaceutical Review
 
Promacta receives Breakthrough Therapy designation for SAA 
European Pharmaceutical Review
Eltrombopag, marketed as Promacta in the United States and Revolade in countries outside the US, is approved in more than 100 countries worldwide for the treatment of thrombocytopenia in adult patients with chronic immune (idiopathic) thrombocytopenic ...

and more »